B of A Securities has initiated coverage on Masimo Corp (MASI), assigning the company a Neutral rating. This marks the firm's first assessment of the company's investment potential, reflecting its research into Masimo's business model, industry dynamics, and growth prospects.
Masimo Corp, headquartered in Irvine, California, is a global technology company focused on developing and marketing patient monitoring technologies and connectivity solutions. The firm employs approximately 3,600 individuals and went public on August 8, 2007. Its healthcare products are sold primarily to hospitals, emergency medical service providers, and physician offices, among others. Notably, Masimo's technologies include advanced pulse oximetry and various monitoring modalities.
As of November 16, 2025, Masimo's shares are priced at $151.12, with a market capitalisation of $7.7 billion. The company has reported a trailing twelve-month earnings per share (EPS) of -8.57. Recent earnings performance indicates a positive trend, with Q3 2025 EPS at $1.32, surpassing estimates by 7.7%.
Analyst ratings can provide insight but should not be the sole basis for investment decisions. It is essential to consider a range of factors, including company fundamentals and market conditions. The consensus among analysts remains bullish, with five Strong Buy, seven Buy, and three Hold ratings noted as of November 1, 2025. Analyst opinions may evolve as new information becomes available, underscoring the importance of comprehensive research in investment choices.